Approval · Notice of Compliance 5626 · 1994
COPTIN: Notice of Compliance 5626
Issued January 14, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5626
- Date
- January 14, 1994
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New source of active ingredient
- Therapeutic class
- Antibacterial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COPTIN | Not yet assigned | — |
Medicinal ingredients
- TRIMETHOPRIM 90 MG per TAB
- SULFADIAZINE 410 MG per TAB
- SULFADIAZINE 820 MG per TAB
- TRIMETHOPRIM 180 MG per TAB
- SULFADIAZINE 41 MG per ML
- TRIMETHOPRIM 9 MG per ML